MobiHealth News June 20, 2025
Anthony Vecchione

Employees will have access to medications through Cost Plus Drugs and 9amHealth’s care team of obesity medical specialists.

9amHealth, a virtual cardiometabolic care company, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), are collaborating to allow 9amHealth to use lower-cost oral meds from Cost Plus Drugs as an alternative to treat obesity.

The company’s obesity program for self-insured employers includes branded GLP-1 medications for obesity through direct manufacturer partnerships.

The two companies aim to target employers seeking to extend coverage for weight management and chronic co-conditions, such as diabetes, high cholesterol and hypertension.

Employees will have access to medications through Cost Plus Drugs, alongside 9amHealth’s care team of obesity medicine physicians, endocrinologists and cardiometabolic specialists.

...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, Partnerships, Pharma, Pharma / Biotech, Technology, Telehealth, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article